PAVmed Inc. Common Stock (PAVM) is a publicly traded Healthcare sector company. As of July 16, 2026, PAVM trades at $6.13 with a market cap of $40.59M and a P/E ratio of -0.55. PAVM moved +8.11% today. Year to date, PAVM is -7.91%; over the trailing twelve months it is -64.51%. Its 52-week range spans $3.85 to $37.50. Analyst consensus is buy with an average price target of $36.00. Rallies surfaces PAVM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PAVM insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $6.13 |
| Market Cap | $40.59M |
| P/E Ratio | -0.55 |
| EPS | $-10.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.50 |
| 52-Week Low | $3.85 |
| Volume | 40.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $85.00K |
| Net Income | $-22.16M |
| Gross Margin | -227.06% |
2 analysts cover PAVM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $36.00.